Private Advisor Group LLC Purchases New Position in HealthEquity, Inc. (NASDAQ:HQY)

Private Advisor Group LLC bought a new position in HealthEquity, Inc. (NASDAQ:HQYFree Report) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 2,544 shares of the company’s stock, valued at approximately $208,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. International Assets Investment Management LLC purchased a new stake in HealthEquity in the 2nd quarter worth approximately $35,000. Paladin Wealth LLC bought a new position in shares of HealthEquity in the 3rd quarter worth $39,000. GAMMA Investing LLC increased its holdings in shares of HealthEquity by 114.8% in the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after buying an additional 318 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of HealthEquity in the 2nd quarter worth $73,000. Finally, Headlands Technologies LLC bought a new position in shares of HealthEquity in the 1st quarter worth $130,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Up 1.7 %

NASDAQ:HQY opened at $98.82 on Friday. The firm has a market cap of $8.63 billion, a P/E ratio of 82.35, a P/E/G ratio of 1.36 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. HealthEquity, Inc. has a fifty-two week low of $62.10 and a fifty-two week high of $99.57. The firm has a 50-day simple moving average of $83.15 and a two-hundred day simple moving average of $80.43.

HealthEquity (NASDAQ:HQYGet Free Report) last released its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. The business had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. Analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Analysts Set New Price Targets

HQY has been the topic of a number of research analyst reports. Royal Bank of Canada reissued an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Barrington Research reaffirmed an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a report on Friday, September 20th. Bank of America reduced their target price on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, September 4th. JMP Securities reaffirmed a “market outperform” rating and set a $105.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $103.83.

Read Our Latest Report on HealthEquity

Insider Buying and Selling at HealthEquity

In other news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In related news, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the sale, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is owned by corporate insiders.

About HealthEquity

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Articles

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.